F&FFinancial Insights

Financial Metrics

BLCO Bausch & Lomb Corp
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 15 | A: 6

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2021-03-31 881000000.0 USD 10-Q 2022-06-08
Quarterly 2021-06-30 934000000.0 +6.0% USD 10-Q 2022-08-04
Quarterly 2021-09-30 949000000.0 +1.6% USD 10-Q 2022-11-02
Quarterly 2022-03-31 889000000.0 -6.3% USD 10-Q 2023-05-03
Quarterly 2022-06-30 941000000.0 +5.8% USD 10-Q 2023-08-02
Quarterly 2022-09-30 942000000.0 +0.1% USD 10-Q 2023-11-01
Quarterly 2023-03-31 931000000.0 -1.2% USD 10-Q 2024-05-01
Quarterly 2023-06-30 1035000000.0 +11.2% USD 10-Q 2024-08-01
Quarterly 2023-09-30 1007000000.0 -2.7% USD 10-Q 2024-10-30
Quarterly 2024-03-31 1099000000.0 +9.1% USD 10-Q 2025-04-30
Quarterly 2024-06-30 1216000000.0 +10.6% USD 10-Q 2025-07-30
Quarterly 2024-09-30 1196000000.0 -1.6% USD 10-Q 2025-10-29
Quarterly 2025-03-31 1137000000.0 -4.9% USD 10-Q 2025-04-30
Quarterly 2025-06-30 1278000000.0 +12.4% USD 10-Q 2025-07-30
Quarterly 2025-09-30 1281000000.0 +0.2% USD 10-Q 2025-10-29
Annual 2020-12-31 3412000000.0 USD 10-K 2023-02-22
Annual 2021-12-31 3765000000.0 +10.3% USD 10-K 2024-02-21
Annual 2022-12-31 3768000000.0 +0.1% USD 10-K 2025-02-19
Annual 2023-12-31 4146000000.0 +10.0% USD 10-K 2026-02-18
Annual 2024-12-31 4791000000.0 +15.6% USD 10-K 2026-02-18
Annual 2025-12-31 5101000000.0 +6.5% USD 10-K 2026-02-18

Gross Profit

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

Operating Income

Q: 15 | A: 6

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2021-03-31 85000000.0 USD 10-Q 2022-06-08
Quarterly 2021-06-30 58000000.0 -31.8% USD 10-Q 2022-08-04
Quarterly 2021-09-30 94000000.0 +62.1% USD 10-Q 2022-11-02
Quarterly 2022-03-31 54000000.0 -42.6% USD 10-Q 2023-05-03
Quarterly 2022-06-30 56000000.0 +3.7% USD 10-Q 2023-08-02
Quarterly 2022-09-30 46000000.0 -17.9% USD 10-Q 2023-11-01
Quarterly 2023-03-31 -2000000.0 -104.3% USD 10-Q 2024-05-01
Quarterly 2023-06-30 43000000.0 +2250.0% USD 10-Q 2024-08-01
Quarterly 2023-09-30 40000000.0 -7.0% USD 10-Q 2024-10-30
Quarterly 2024-03-31 6000000.0 -85.0% USD 10-Q 2025-04-30
Quarterly 2024-06-30 26000000.0 +333.3% USD 10-Q 2025-07-30
Quarterly 2024-09-30 43000000.0 +65.4% USD 10-Q 2025-10-29
Quarterly 2025-03-31 -83000000.0 -293.0% USD 10-Q 2025-04-30
Quarterly 2025-06-30 -11000000.0 +86.7% USD 10-Q 2025-07-30
Quarterly 2025-09-30 95000000.0 +963.6% USD 10-Q 2025-10-29
Annual 2020-12-31 260000000.0 USD 10-K 2023-02-22
Annual 2021-12-31 329000000.0 +26.5% USD 10-K 2024-02-21
Annual 2022-12-31 207000000.0 -37.1% USD 10-K 2025-02-19
Annual 2023-12-31 130000000.0 -37.2% USD 10-K 2026-02-18
Annual 2024-12-31 162000000.0 +24.6% USD 10-K 2026-02-18
Annual 2025-12-31 113000000.0 -30.2% USD 10-K 2026-02-18

Net Income

Q: 15 | A: 6

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2021-03-31 30000000.0 USD 10-Q 2022-06-08
Quarterly 2021-06-30 46000000.0 +53.3% USD 10-Q 2022-08-04
Quarterly 2021-09-30 63000000.0 +37.0% USD 10-Q 2022-11-02
Quarterly 2022-03-31 23000000.0 -63.5% USD 10-Q 2023-05-03
Quarterly 2022-06-30 7000000.0 -69.6% USD 10-Q 2023-08-02
Quarterly 2022-09-30 -15000000.0 -314.3% USD 10-Q 2023-11-01
Quarterly 2023-03-31 -88000000.0 -486.7% USD 10-Q 2024-05-01
Quarterly 2023-06-30 -29000000.0 +67.0% USD 10-Q 2024-08-01
Quarterly 2023-09-30 -80000000.0 -175.9% USD 10-Q 2024-10-30
Quarterly 2024-03-31 -163000000.0 -103.8% USD 10-Q 2025-04-30
Quarterly 2024-06-30 -148000000.0 +9.2% USD 10-Q 2025-07-30
Quarterly 2024-09-30 8000000.0 +105.4% USD 10-Q 2025-10-29
Quarterly 2025-03-31 -211000000.0 -2737.5% USD 10-Q 2025-04-30
Quarterly 2025-06-30 -58000000.0 +72.5% USD 10-Q 2025-07-30
Quarterly 2025-09-30 -25000000.0 +56.9% USD 10-Q 2025-10-29
Annual 2020-12-31 -17000000.0 USD 10-K 2023-02-22
Annual 2021-12-31 193000000.0 +1235.3% USD 10-K 2024-02-21
Annual 2022-12-31 15000000.0 -92.2% USD 10-K 2025-02-19
Annual 2023-12-31 -248000000.0 -1753.3% USD 10-K 2026-02-18
Annual 2024-12-31 -305000000.0 -23.0% USD 10-K 2026-02-18
Annual 2025-12-31 -352000000.0 -15.4% USD 10-K 2026-02-18

EPS Basic

Q: 15 | A: 6

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2021-03-31 0.08 USD/shares 10-Q 2022-06-08
Quarterly 2021-06-30 0.13 +62.5% USD/shares 10-Q 2022-08-04
Quarterly 2021-09-30 0.17 +30.8% USD/shares 10-Q 2022-11-02
Quarterly 2022-03-31 0.06 -64.7% USD/shares 10-Q 2023-05-03
Quarterly 2022-06-30 0.01 -83.3% USD/shares 10-Q 2023-08-02
Quarterly 2022-09-30 -0.05 -600.0% USD/shares 10-Q 2023-11-01
Quarterly 2023-03-31 -0.26 -420.0% USD/shares 10-Q 2024-05-01
Quarterly 2023-06-30 -0.09 +65.4% USD/shares 10-Q 2024-08-01
Quarterly 2023-09-30 -0.24 -166.7% USD/shares 10-Q 2024-10-30
Quarterly 2024-03-31 -0.48 -100.0% USD/shares 10-Q 2025-04-30
Quarterly 2024-06-30 -0.43 +10.4% USD/shares 10-Q 2025-07-30
Quarterly 2024-09-30 0.01 +102.3% USD/shares 10-Q 2025-10-29
Quarterly 2025-03-31 -0.6 -6100.0% USD/shares 10-Q 2025-04-30
Quarterly 2025-06-30 -0.18 +70.0% USD/shares 10-Q 2025-07-30
Quarterly 2025-09-30 -0.08 +55.6% USD/shares 10-Q 2025-10-29
Annual 2020-12-31 -0.05 USD/shares 10-K 2023-02-22
Annual 2021-12-31 0.52 +1140.0% USD/shares 10-K 2024-02-21
Annual 2022-12-31 0.02 -96.2% USD/shares 10-K 2025-02-19
Annual 2023-12-31 -0.74 -3800.0% USD/shares 10-K 2026-02-18
Annual 2024-12-31 -0.9 -21.6% USD/shares 10-K 2026-02-18
Annual 2025-12-31 -1.02 -13.3% USD/shares 10-K 2026-02-18

EPS Diluted

Q: 15 | A: 6

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2021-03-31 0.08 USD/shares 10-Q 2022-06-08
Quarterly 2021-06-30 0.13 +62.5% USD/shares 10-Q 2022-08-04
Quarterly 2021-09-30 0.17 +30.8% USD/shares 10-Q 2022-11-02
Quarterly 2022-03-31 0.06 -64.7% USD/shares 10-Q 2023-05-03
Quarterly 2022-06-30 0.01 -83.3% USD/shares 10-Q 2023-08-02
Quarterly 2022-09-30 -0.05 -600.0% USD/shares 10-Q 2023-11-01
Quarterly 2023-03-31 -0.26 -420.0% USD/shares 10-Q 2024-05-01
Quarterly 2023-06-30 -0.09 +65.4% USD/shares 10-Q 2024-08-01
Quarterly 2023-09-30 -0.24 -166.7% USD/shares 10-Q 2024-10-30
Quarterly 2024-03-31 -0.48 -100.0% USD/shares 10-Q 2025-04-30
Quarterly 2024-06-30 -0.43 +10.4% USD/shares 10-Q 2025-07-30
Quarterly 2024-09-30 0.01 +102.3% USD/shares 10-Q 2025-10-29
Quarterly 2025-03-31 -0.6 -6100.0% USD/shares 10-Q 2025-04-30
Quarterly 2025-06-30 -0.18 +70.0% USD/shares 10-Q 2025-07-30
Quarterly 2025-09-30 -0.08 +55.6% USD/shares 10-Q 2025-10-29
Annual 2020-12-31 -0.05 USD/shares 10-K 2023-02-22
Annual 2021-12-31 0.52 +1140.0% USD/shares 10-K 2024-02-21
Annual 2022-12-31 0.02 -96.2% USD/shares 10-K 2025-02-19
Annual 2023-12-31 -0.74 -3800.0% USD/shares 10-K 2026-02-18
Annual 2024-12-31 -0.9 -21.6% USD/shares 10-K 2026-02-18
Annual 2025-12-31 -1.02 -13.3% USD/shares 10-K 2026-02-18

8-K Material Event Details

49 filings · 107 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

65 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-03-06 Bailey A Robert D EVP & Chief Legal Officer Equity grant / award
A
Common Shares, No Par Value 14,600 $0.00 $0 246,490
2026-03-06 Bailey A Robert D EVP & Chief Legal Officer Open-market buy
P
Common Shares, No Par Value 14,600 $17.15 $250,332 231,890
2026-03-03 Ross Thomas W. Sr. Dir Equity grant / award
A
Common Shares, No Par Value 4,500 $0.00 $0 69,391
2026-03-03 Ross Thomas W. Sr. Dir Open-market buy
P
Common Shares, No Par Value 4,500 $17.68 $79,556 64,891
2026-03-02 Alfonso Eduardo Dir Equity grant / award
A
Common Shares, No Par Value 4,300 $0.00 $0 13,855
2026-03-02 Alfonso Eduardo Dir Open-market buy
P
Common Shares, No Par Value 4,300 $17.90 $76,970 9,555
2026-02-27 Munsch Frederick SVP, Controller and CAO Other disposed transaction
F
Common Shares, No Par Value 5,692 $18.30 $104,164 98,313
2026-02-27 Munsch Frederick SVP, Controller and CAO Other disposed transaction
F
Common Shares, No Par Value 2,437 $18.30 $44,597 104,005
2026-02-27 VON ESCHENBACH ANDREW C. Dir Equity grant / award
A
Common Shares, No Par Value 4,364 $0.00 $0 70,814
2026-02-27 VON ESCHENBACH ANDREW C. Dir Open-market buy
P
Common Shares, No Par Value 4,364 $18.30 $79,883 66,450
2026-02-26 Munsch Frederick SVP, Controller and CAO Other disposed transaction
F
Common Shares, No Par Value 2,042 $18.49 $37,757 106,442
2026-02-25 Munsch Frederick SVP, Controller and CAO Equity grant / award
A
Common Shares, No Par Value 18,253 $0.00 $0 108,484
2026-02-23 SAUNDERS BRENT L CEO and Chairman of the Board Other disposed transaction
F
Common Shares, No Par Value 65,444 $17.99 $1,177,338 671,481
2026-02-20 ROBERTSON RUSSEL C Dir Equity grant / award
A
Common Shares, No Par Value 4,400 $0.00 $0 76,807
2026-02-20 ROBERTSON RUSSEL C Dir Open-market buy
P
Common Shares, No Par Value 4,400 $17.90 $78,760 72,407
2026-02-19 Ling Karen Dir Equity grant / award
A
Common Shares, No Par Value 4,000 $0.00 $0 45,676
2026-02-19 Ling Karen Dir Open-market buy
P
Common Shares, No Par Value 4,000 $17.74 $70,968 41,676
2026-02-18 Munsch Frederick SVP, Controller and CAO Equity grant / award
A
Common Shares, No Par Value 12,498 $0.00 $0 90,231
2025-11-14 ROBERTSON RUSSEL C Dir Equity grant / award
A
Common Shares, No Par Value 1,642 $15.60 $25,615 66,556
2025-08-05 Munsch Frederick SVP, Controller and CAO Equity grant / award
A
Common Shares, No Par Value 7,529 $0.00 $0 77,733
2025-07-25 Hashad Yehia EVP of R&D and CMO Other disposed transaction
F
Common Shares, No Par Value 2,841 $14.32 $40,683 116,739
2025-07-21 SAUNDERS BRENT L CEO and Chairman of the Board Equity grant / award
A · derivative
Performance Stock Units 150,000 $0.00 $0 900,000
2025-06-13 Bonnefoy Luc President, Surgical Other disposed transaction
F
Common Shares, No Par Value 968 $12.33 $11,935 73,383
2025-05-27 VON ESCHENBACH ANDREW C. Dir Equity grant / award
A
Common Shares, No Par Value 20,338 $0.00 $0 62,086
2025-05-22 SAUNDERS BRENT L CEO and Chairman of the Board Equity grant / award
A
Common Shares, No Par Value 22,000 $0.00 $0 741,156
2025-05-22 SAUNDERS BRENT L CEO and Chairman of the Board Open-market buy
P
Common Shares, No Par Value 22,000 $11.28 $248,072 719,156
2025-05-02 VON ESCHENBACH ANDREW C. Dir Open-market buy
P
Common Shares, No Par Value 1,695 $11.76 $19,925 41,748
2025-05-01 ROBERTSON RUSSEL C Dir Equity grant / award
A
Common Shares, No Par Value 2,210 $11.59 $25,614 44,576
2025-04-24 Stewart Andrew J. See remarks Other disposed transaction
F
Common Shares, No Par Value 3,954 $13.89 $54,921 62,930
2025-02-28 Bonnefoy Luc President,Surgical Other disposed transaction
F
Common Shares, No Par Value 3,029 $16.00 $48,464 74,351
2025-02-28 Bonnefoy Luc President,Surgical Other disposed transaction
F
Common Shares, No Par Value 1,110 $16.00 $17,760 77,380
2025-02-26 Munsch Frederick SVP, Controller and CAO Equity grant / award
A
Common Shares, No Par Value 18,581 $0.00 $0 71,294
2024-12-23 Stewart Andrew J. See remarks Other disposed transaction
F
Common Shares, No Par Value 2,524 $17.83 $45,003 43,461
2024-09-30 ROBERTSON RUSSEL C Dir Equity grant / award
A
Common Shares, No Par Value 1,328 $19.29 $25,617 43,694
2024-08-05 SAUNDERS BRENT L CEO and Chairman of the Board Equity grant / award
A
Common Shares, No Par Value 32,250 $0.00 $0 627,419
2024-08-05 SAUNDERS BRENT L CEO and Chairman of the Board Open-market buy
P
Common Shares, No Par Value 32,250 $15.66 $505,067 595,169
2024-08-02 VON ESCHENBACH ANDREW C. Dir Equity grant / award
A
Common Shares, No Par Value 14,696 $0.00 $0 40,053
2024-07-25 Munsch Frederick SVP, Controller and CAO Other disposed transaction
F
Common Shares, No Par Value 1,313 $15.53 $20,391 55,813
2024-06-28 Paulson John Dir Equity grant / award
A
Common Shares, No Par Value 1,506 $14.52 $21,867 33,044
2024-06-14 Bonnefoy Luc President,Surgical Other disposed transaction
F
Common Shares, No Par Value 958 $15.09 $14,456 57,211
2024-04-24 Stewart Andrew J. See remarks Other disposed transaction
F
Common Shares, No Par Value 3,943 $14.90 $58,751 45,985
2024-03-29 ROBERTSON RUSSEL C Dir Equity grant / award
A
Common Shares, No Par Value 1,481 $17.30 $25,621 25,906
2024-03-05 Ling Karen Dir Equity grant / award
A
Common Shares, No Par Value 2,642 $0.00 $0 2,642
2024-03-01 Hashad Yehia EVP of R&D and CMO Other disposed transaction
F
Common Shares, No Par Value 2,143 $16.47 $35,295 102,271
2024-02-28 Munsch Frederick SVP, Controller and CAO Equity grant / award
A
Common Shares, No Par Value 18,183 $0.00 $0 58,121
2023-12-29 ROBERTSON RUSSEL C Dir Equity grant / award
A
Common Shares, No Par Value 1,502 $17.06 $25,624 24,425
2023-09-29 ROBERTSON RUSSEL C Dir Equity grant / award
A
Common Shares, No Par Value 1,511 $16.95 $25,611 22,923
2023-07-25 Munsch Frederick SVP, Controller and CAO Other disposed transaction
F
Common Shares, No Par Value 1,313 $19.82 $26,024 39,938
2023-06-30 ROBERTSON RUSSEL C Dir Equity grant / award
A
Common Shares, No Par Value 1,276 $20.07 $25,609 21,412
2023-06-14 Bonnefoy Luc President,Surgical Equity grant / award
A
Common Shares, No Par Value 5,361 $0.00 $0 44,729
2023-05-04 Bailey A Robert D EVP & Chief Legal Officer Equity grant / award
A · derivative
Non-Qualified Stock Options (right to purchase) 429,184 $0.00 $0 429,184
2023-04-24 Stewart Andrew J. See remarks Equity grant / award
A
Common Shares, No Par Value 33,150 $0.00 $0 33,150
2023-03-31 ROBERTSON RUSSEL C Dir Equity grant / award
A
Common Shares, No Par Value 1,471 $17.41 $25,610 13,971
2023-03-01 Munsch Frederick SVP, Controller and CAO Equity grant / award
A · derivative
Non-Qualified Stock Options (right to purchase) 24,103 $0.00 $0 24,103
2023-03-01 Munsch Frederick SVP, Controller and CAO Equity grant / award
A
Common Shares, No Par Value 7,529 $0.00 $0 41,251
2022-12-30 Bernier Nathalie D. Dir Equity grant / award
A
Common Shares, No Par Value 1,625 $15.51 $25,204 16,380
2022-09-30 Bernier Nathalie D. Dir Equity grant / award
A
Common Shares, No Par Value 1,507 $15.34 $23,117 14,755
2022-07-27 Munsch Frederick SVP, Controller and CAO Equity grant / award
A
Common Shares, No Par Value 11,500 $0.00 $0 33,722
2022-07-25 Hashad Yehia EVP, R&D and CMO Equity grant / award
A
Common Shares, No Par Value 35,000 $0.00 $0 69,722
2022-06-30 Bernier Nathalie D. Dir Equity grant / award
A
Common Shares, No Par Value 748 $15.24 $11,400 13,248
2022-06-28 Hu Gaoxiang Dir Equity grant / award
A
Common Shares, No Par Value 13,256 $0.00 $0 13,256
2022-06-01 Bausch Health Companies Inc. 10% Open-market sell
S
Common Shares, No Par Value 4,550,357 $17.05 $77,606,339 310,449,643
2022-05-10 Bernier Nathalie D. Dir Equity grant / award
A
Common Shares, No Par Value 12,500 $0.00 $0 12,500
2022-05-05 Gordon Joseph F Please see remarks Equity grant / award
A · derivative
Non-Qualified Stock Options (right to purchase) 274,725 $0.00 $0 274,725
2022-05-05 Gordon Joseph F Please see remarks Equity grant / award
A
Common Shares, No Par Value 69,444 $0.00 $0 69,444

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
20
Material Event Filings (8-K) — 12 months
16

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.